![Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4760347/bin/nihms756182f1b.jpg)
Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC
![Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4760347/bin/nihms756182f1d.jpg)
Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC
![PDF) Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome PDF) Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome](https://i1.rgstatic.net/publication/281780696_Bohring-Opitz_syndrome_BOS_with_a_new_ASXL1_pathogenic_variant_Review_of_the_most_prevalent_molecular_and_phenotypic_features_of_the_syndrome/links/5c094268299bf139c7433c4a/largepreview.png)
PDF) Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome
![Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis | European Journal of Human Genetics Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis | European Journal of Human Genetics](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fejhg.2010.234/MediaObjects/41431_2011_Article_BFejhg2010234_Fig1_HTML.jpg)
Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis | European Journal of Human Genetics
![Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4760347/bin/nihms756182f1a.jpg)
Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance. - Abstract - Europe PMC
![Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis | European Journal of Human Genetics Bohring–Opitz (Oberklaid–Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis | European Journal of Human Genetics](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fejhg.2010.234/MediaObjects/41431_2011_Article_BFejhg2010234_Fig1_HTML.jpg)